NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bloom Science

Bloom Science

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://bloomscience.com/

Last Round

Series A

Dec 9, 2021

Total Funding Raised

$12.5M

Company Overview

Bloom Science is a biotechnology company that develops live biotherapeutic products and genetically optimized living medicines for severe metabolic and neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

live biotherapeutic productsLBPgut-brain axisdrug discovery platformmicrobiome therapeuticsketogenic dietsynthetic biologymultiomicsmetabolic disordersneurological disordersbiotechmicrobiome drugsclinical stageai drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bloom Science Comparables

Compare Bloom Science with similar companies based on industry and business-model similarity.

Bloom Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
YSOPIA Bioscience
78%
Genome & Company
78%
New Biotic, Inc.
77%

Bloom Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 9, 2021
GrantMar 17, 2020
GrantSep 3, 2019
SeedMay 24, 2018

Key People

Founding team and executive leadership

Christopher Reyes

CEO, Co-Founder, Director

Founding Team

Bloom Science Investors

Notable investors and investment history

Bloom Science investors
InvestorRounds
The ALS AssociationGrant
Epilepsy FoundationGrant
ALS Investment FundSeries A
Joyance PartnersSeed, Series A
Leaps by BayerSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Leadership team to speak at Sachs Neuroscience Innovation Forum.

  • Jan 8, 2026

    Leadership to present at the J.P. Morgan Healthcare Conference.

Bloom Science Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bloom Science Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bloom Science's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range17
Year Founded2018
Last FundingDec 9, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.